LP(A) TESTING IN A REAL-WORLD POPULATION OF US ADULTS
Purpose/Goal(s): Lipoprotein (a) [Lp(a)] is a strong marker for Cardiovasular (CV) risk. Perhaps because there has not been a clear therapy for elevated Lp(a), this marker is rarely checked in practice. As novel therapies become available, it will be important to increase physician awareness and testing of Lp(a). First, we must understand which patients are having their Lp(a) checked in real-world settings, and what happens to these patients.
Study Design: Query based on data in the PCORnet CDM 4.1
Coordinating Center: Duke Clinical Research Institute